Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
111 SEK | +0.41% | -0.36% | +12.60% |
03-11 | SECURITAS : Involved in more technology and solutions | |
03-07 | Nordic Stocks Moved Upward Thursday; Zealand Pharma Topped Leaders | DJ |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 11.66 for the current year.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.62 for the 2024 fiscal year.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Business Support Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+12.60% | 5.78B | B- | ||
-18.97% | 2.04B | - | D+ | |
-6.14% | 925M | B+ | ||
-1.86% | 823M | B | ||
+2.63% | 819M | C | ||
-16.79% | 535M | - | - | |
+47.64% | 493M | - | - | |
+2.48% | 486M | - | - | |
+7.81% | 252M | - | ||
+28.80% | 107M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SECU B Stock
- Ratings Securitas AB